GENAISSANCE PHARMACEUTICALS INC
S-8, EX-23.1, 2000-12-20
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: GENAISSANCE PHARMACEUTICALS INC, S-8, EX-5.1, 2000-12-20
Next: MONSANTO CO /NEW/, 4/A, 2000-12-20



<PAGE>

                                                                  Exhibit 23.1

                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

The Board of Directors
Genaissance Pharmaceuticals, Inc.:

As independent public accountants, we hereby consent to the incorporation by
reference in this registration statement of our report dated March 10, 2000
included in Genaissance Pharmaceuticals, Inc.'s registration statement on Form
S-1 (File No. 333-35314), and to all references to our Firm included in this
registration statement.



                                                     /s/  Arthur Andersen LLP


Hartford, Connecticut
December 18, 2000






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission